Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Halilovic
Inhibition of Wild-Type P53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
IOX-101, a Novel Small Molecule, Reduces AML Cell Proliferation by Akt Enzyme Inhibition
Archives of Biological Sciences
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
Discovery of SCY45, a Natural Small‐Molecule MDM2‐p53 Interaction Inhibitor.
Chemistry and Biodiversity
Molecular Medicine
Molecular Biology
Biochemistry
Medicine
Bioengineering
Chemistry
Stereochemical Studies of Hexylitaconic Acid, an Inhibitor of P53–HDM2 Interaction
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Pharmacologic Activation of P53 by Small-Molecule MDM2 Antagonists
Current Pharmaceutical Design
Drug Discovery
Pharmacology
Apoptotic Signaling Pathways Induced by Nitric Oxide in Human Lymphoblastoid Cells Expressing Wild-Type or Mutant P53
Cancer Research
Cancer Research
Oncology
A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced P53 Degradation by HDM2 in Response to DNA Damage
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Wild-Type P53-Mediated Induction of Ratmdr1bExpression by the Anticancer Drug Daunorubicin
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Specific Domains of Nucleolin Interact With Hdm2 and Antagonize Hdm2-Mediated P53 Ubiquitination
FEBS Journal
Biochemistry
Cell Biology
Molecular Biology
Small-Molecule Inhibition of Wee1 Kinase by MK-1775 Selectively Sensitizes P53-Deficient Tumor Cells to DNA-damaging Agents
Molecular Cancer Therapeutics
Cancer Research
Oncology
